Jan Brackow

A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration.

J. Snyder, Simak Ali, R. Coombes, 2010, Journal of medicinal chemistry.

The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.

J. Snyder, Simak Ali, R. Coombes, 2009, Cancer research.

Inhibitor That Shows Antitumor Activity The Development of a Selective Cyclin-Dependent Kinase

J. Snyder, Simak Ali, R. Coombes, 2009 .